Abstract
The discovery of novel intervention points in the inflammatory pathway has been a focus of drug development in recent years. We have identified pathway selective ligands for the estrogen receptor (ER) that inhibit NF-kB mediated inflammatory gene expression causing a reduction of cytokines, chemokines, adhesion molecules and inflammatory enzymes. SAR development of a series of 4-(Indazol-3-yl)-phenols has led to the identification of WAY-169916 an orally active non-steroidal ligand with the potential use in the treatment of inflammatory diseases without the classical proliferative effects associated with non-selective estrogens.
Keywords: Estrogen receptor, ER, nuclear factor kappa B, NF-kB
Current Topics in Medicinal Chemistry
Title: Control of Chronic Inflammation with Pathway Selective Estrogen Receptor Ligands
Volume: 6 Issue: 2
Author(s): Robert J. Steffan, Edward Matelan, Mark A. Ashwell, William J. Moore, William R. Solvibile, Eugene Trybulski, Christopher C. Chadwick, Susan Chippari, Thomas Kenney, Richard C. Winneker, Amy Eckert, Lisa Borges-Marcucci, Steven J. Adelman, Zhang Xu, Lydia Mosyak and Douglas C. Harnish
Affiliation:
Keywords: Estrogen receptor, ER, nuclear factor kappa B, NF-kB
Abstract: The discovery of novel intervention points in the inflammatory pathway has been a focus of drug development in recent years. We have identified pathway selective ligands for the estrogen receptor (ER) that inhibit NF-kB mediated inflammatory gene expression causing a reduction of cytokines, chemokines, adhesion molecules and inflammatory enzymes. SAR development of a series of 4-(Indazol-3-yl)-phenols has led to the identification of WAY-169916 an orally active non-steroidal ligand with the potential use in the treatment of inflammatory diseases without the classical proliferative effects associated with non-selective estrogens.
Export Options
About this article
Cite this article as:
Steffan J. Robert, Matelan Edward, Ashwell A. Mark, Moore J. William, Solvibile R. William, Trybulski Eugene, Chadwick C. Christopher, Chippari Susan, Kenney Thomas, Winneker C. Richard, Eckert Amy, Borges-Marcucci Lisa, Adelman J. Steven, Xu Zhang, Mosyak Lydia and Harnish C. Douglas, Control of Chronic Inflammation with Pathway Selective Estrogen Receptor Ligands, Current Topics in Medicinal Chemistry 2006; 6 (2) . https://dx.doi.org/10.2174/156802606775270279
DOI https://dx.doi.org/10.2174/156802606775270279 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Prophylactic Admission of an In Vitro Reconstructed Complexes of Human Recombinant Heat Shock Proteins and Melanoma Antigenic Peptides Activates Anti-Melanoma Responses in Mice
Current Molecular Medicine Red Cell Membrane Lipids in Hemoglobinopathies
Current Molecular Medicine An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants
Current Neuropharmacology Estrogen, Neuroprotection and Neurogenesis after Ischemic Stroke
Current Drug Targets Natural Products Towards the Discovery of Potential Future Antithrombotic Drugs
Current Pharmaceutical Design Dissecting the Therapeutic Potency of Antimicrobial Peptides Against Microbial Biofilms
Current Protein & Peptide Science Reduction of Hyperproduction of Thyroid Autoantibodies in Patients without Disturbance of the Thyroid Function: New Patents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Metabolism of Nucleosides and Nucleotides Prodrugs
Current Pharmaceutical Design Clinical Evaluation of the Effect of Blueberries Consumption on Chronic Diseases, Illness Prevention and Health Promotion
The Natural Products Journal “Bedside-to-Bench” Behavioral Outcomes in Animal Models of Pain: Beyond the Evaluation of Reflexes
Current Neuropharmacology Neurobehavioral Differences Between Mice Receiving Distinct Neuregulin Variants as Neonates; Impact on Sensitivity to MK-801
Current Molecular Medicine Functions of S100 Proteins
Current Molecular Medicine Rheumatoid Arthritis: Conjugating Basics with Drug Delivery
Current Rheumatology Reviews Nevirapine-Based Regimens in Routine Clinical Settings: Results from a Large Italian Cohort of HIV-1 Infected Adults
Current Drug Safety Nef: “Necessary and Enforcing Factor” in HIV Infection
Current HIV Research Patent Selections
Recent Patents on Drug Delivery & Formulation An Updated Review on COVID-19
Infectious Disorders - Drug Targets Humoral Immunity in Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Autophagy Modulators and Neuroinflammation
Current Medicinal Chemistry Studies on Non-synonymous Polymorphisms Altering Human DNA Topoisomerase II-Alpha Interaction with Amsacrine and Mitoxantrone: An <i>In Silico</i> Approach
Current Cancer Drug Targets